当前位置:
X-MOL 学术
›
Bioorg. Med. Chem. Lett.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters ( IF 2.5 ) Pub Date : 2009-08-07 , DOI: 10.1016/j.bmcl.2009.08.010 Pierre Tessier , David V. Smil , Amal Wahhab , Silvana Leit , Jubrail Rahil , Zuomei Li , Robert Déziel , Jeffrey M. Besterman
中文翻译:
二苯基亚甲基异羟肟酸作为选择性的IIa类组蛋白脱乙酰基酶抑制剂
更新日期:2009-08-07
Bioorganic & Medicinal Chemistry Letters ( IF 2.5 ) Pub Date : 2009-08-07 , DOI: 10.1016/j.bmcl.2009.08.010 Pierre Tessier , David V. Smil , Amal Wahhab , Silvana Leit , Jubrail Rahil , Zuomei Li , Robert Déziel , Jeffrey M. Besterman
We have identified a series of diphenylmethylene hydroxamic acids as novel and selective HDAC class IIa inhibitors. The original hit, N-hydroxy-2,2-diphenylacetamide (6), has sub-micromolar class IIa HDAC inhibitory activity, while the rigidified oxygen analogue, N-hydroxy-9H-xanthene-9-carboxamide (13), is slightly more selective for HDAC7 with an IC50 of 0.05 μM. Substitution of 6 allows for the modulation of selectivity and potency amongst the class IIa HDAC isotypes.
中文翻译:
二苯基亚甲基异羟肟酸作为选择性的IIa类组蛋白脱乙酰基酶抑制剂
我们已经鉴定出一系列二苯基亚甲基异羟肟酸作为新型和选择性的HDAC IIa类抑制剂。最初的产物N-羟基-2,2-二苯乙酰胺(6)具有亚微摩尔IIa类HDAC抑制活性,而刚性的氧类似物N-羟基9 H-并蒽9-羧酰胺(13)具有抑制作用。IC 50为0.05μM时对HDAC7的选择性更高。取代6可在IIa类HDAC同种型之间调节选择性和效能。